|
⚲
|
| Intekrin Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001360245 |
| Sale | 2008-07-01 ($21.9 M Offered, $21.4 M Sold) |
| Fund | |
| Phone | 6509415501 |
| Address | 4300 El Camino Real Los Altos, 94022 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
PLx Pharma Inc.
✚
|
0.0 | |
|
PLX Technology Inc
✚
|
0.0 | |
|
Plymouth Lane Partners (Offshore), Ltd.
✚
|
0.0 | |
|
PMA Capital Management Limited
✚
|
0.0 | |
|
PMA Europe LLP
✚
|
0.0 | |
|
PM Capital Limited
✚
|
0.0 | |
|
PM Coinvest IX LP
✚
|
0.0 | |
|
PMF Fund, L.P.
✚
|
0.0 | |
|
PMF TEI Fund, L.P.
✚
|
0.0 | |
|
Plutus Insurance Holdings, LLC
✚
|
0.0 |